Scientists launch £9 million study to advance personalized cancer therapies in the UK

Scientists are launching a £9 million study to explore new personalized cancer therapies. This project, led by the Francis Crick Institute, aims to assess the effectiveness of immunotherapy treatments and improve cancer detection methods over four years. The study will analyze tumors and blood samples from 3,000 cancer patients to identify biomarkers that could indicate undetected cancer or the likelihood of recurrence. It will focus on melanoma, kidney cancer, bladder cancer, and triple negative breast cancer. This initiative is part of a larger £118 million investment to develop health technologies in the UK. Other projects include portable imaging tools and a digital pathology data network to enhance cancer research and treatment capabilities.